anchor instance (Q110166)

From ScienceSource
Revision as of 07:15, 17 April 2019 by Charles Matthews (talk | contribs) (‎Created claim: Property:P24: Item:Q110167)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
No description defined
edit
Language Label Description Also known as
English
anchor instance
No description defined

    Statements

    doubled−18,7360.49−38,330Utility decrement of GI adverse events doubled−18,7360.49−38,329Probability of
    0 references
    of SAXA+MET equal to ACAR+MET−18,7370.49−38,622Utility decrement of hypoglycemia doubled−18,7360.49−37,961Discount
    0 references
    184
    0 references
    85
    0 references
    29,541
    0 references
    17 April 2019
    0 references
    0 references
    Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China (5119856)
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit